MBX Biosciences, Inc. (MBX) stock

MBXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30

$55.94+1.43 (+2.62%)

Close on Nov 13, 2026Market cap $2.69BP/E –Yield –

MBX Biosciences gross margin

Gross margin is gross profit as a percentage of revenue.

MBX Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?